This is a fairly classic presentation of a mental mononeuropathy, also known as "numb chin syndrome." While many etiologies exist, the most common etiology is likely iatrogenic (i.e., associated with dental procedures) or a manifestation of a primary dental/maxillofacial pathology (e.g., abscess, mandibular osteomyelitis). However, for the neurologist, and particularly for the RITE and ABPN exams, this syndrome should always elicit the differential of metastatic disease to the mandible from an as of yet unidentified malignancy. In a woman of this age, without past medical history, one would want to ensure that she is up to date on her cancer screening, mammography in particular, given that breast cancer is the most frequent malignancy associated with this disorder in some series.
While electrodiagnostic testing can be routinely performed to evaluate the trigeminal nerve (e.g., blink reflex), the most appropriate diagnostic test to order in this case would be an imaging study (CT and/or MRI) of the mandible/face specifically protocoled to evaluate the mental, and more proximal, trigeminal nerve. It is important to recognize that while lesions are commonly identified near the mental foramen or nearby in the mandible, more proximal lesions of the trigeminal nerve can also result in numb chin syndrome and so the entire course of the nerve should be imaged. While she does not have trigeminal neuralgia, but rather a trigeminal branch mononeuropathy, it would be inappropriate to send the patient back to the referring doctor, who has clearly requested your expertise in identifying the etiology of this woman's syndrome, simply because their working diagnosis was inaccurate. While a prompt CT scan of the face/mandible/skull base certainly may be a reasonable first diagnostic step, there is no indication from the case provided that this patient needs to be sent to the emergency room for imaging. Starting a symptomatic therapy without initiating a workup to identify the etiology is also not appropriate. Furthermore, carbamazepine is unlikely to help the "negative" sensory symptoms present in this case, as it is a medication effective in treating the "positive" symptoms (i.e., lancinating pain) present in conditions such as trigeminal neurlagia. And in an elderly patient this agent is likely to only have adverse effects without any potential benefit.
Reference: